Effects of the theory of planned behavior and nudge strategy-based intervention on the adherence to anticoagulation treatment in patients with non-valvular atrial fibrillation

被引:6
|
作者
Ding, Yaoyao [1 ]
Jiang, Hui [2 ]
Liu, Jingzhe [1 ]
Chen, Dexin [1 ]
Yang, Fuguo [1 ]
机构
[1] Qingdao Univ, Sch Nursing, Qingdao 266071, Shandong, Peoples R China
[2] Univ Hlth & Rehabil Sci, Qingdao Hosp, Qingdao Municipal Hosp, Emergency Dept, Qingdao 266000, Shandong, Peoples R China
关键词
Non -valvular atrial fibrillation; Anticoagulation; The theory of planned behavior; Nudge; MEDICATION ADHERENCE; RISK;
D O I
10.1016/j.gerinurse.2023.01.023
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Non-valvular atrial fibrillation is associated with the incidence of thromboembolism. Current guidelines recommend preferential use of novel oral anticoagulants (NOAC) in patients with nonvalvular atrial fibrillation. Oral anticoagulation medication adherence rate was relatively low among discharged patients with non-valvular atrial fibrillation.Aim: To investigate the effects of the anticoagulation programs based on the theory of planned behavior and nudge strategy among patients with non-valvular atrial fibrillation.Methods: 130 patients with non-valvular atrial fibrillation were randomized to the intervention group or con-trol group, 72 patients in the intervention group, and 58 patients in the control group with a 6-month follow-up. Medication adherence, intention, attitude, perceived behavioral control and subjective norm and quality of life were assessed.Results: There were significantly differences in the intention, attitude and subjective norm between the two groups at one month, three months and six months follow-up (P <0.01). There were significantly differences in the perceived behavioral control between the two groups at three months and six months follow-up (P <0.01). The medication adherence scale score was higher in the intervention group than in the control group at three months and six months follow-up. However, there were no differences in quality of life between the two groups at one month, three months and six months follow-up.Conclusions: The program based on the theory of planned behavior and nudge strategy can improve medica-tion adherence in patients with non-valvular atrial fibrillation.(c) 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页码:17 / 24
页数:8
相关论文
共 50 条
  • [21] New Era of Oral Anticoagulation for Japanese Non-Valvular Atrial Fibrillation Patients
    Hirano, Teruyuki
    CIRCULATION JOURNAL, 2014, 78 (06) : 1317 - 1319
  • [22] Application of a Decision Support Tool for Anticoagulation in Patients with Non-valvular Atrial Fibrillation
    Mark L. Wess
    Daniel P. Schauer
    Joseph A. Johnston
    Charles J. Moomaw
    David E. Brewer
    E. Francis Cook
    Mark H. Eckman
    Journal of General Internal Medicine, 2008, 23 : 411 - 417
  • [23] Practice patterns and adherence to ACCP anticoagulation therapy guidelines among chronic non-valvular atrial fibrillation patients
    Stephenson, JJ
    Hauch, O
    Beaulieu, JF
    Kim, J
    Fernandes, J
    CIRCULATION, 2004, 109 (20) : E267 - E267
  • [24] Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non-valvular atrial fibrillation (cognitive decline and dementia in patients with non-valvular atrial fibrillation [CAF] trial)
    Bunch, Thomas Jared
    May, Heidi
    Cutler, Michael
    Woller, Scott C.
    Jacobs, Victoria
    Stevens, Scott M.
    Carlquist, John
    Knowlton, Kirk U.
    Muhlestein, Joseph B.
    Steinberg, Benjamin A.
    Anderson, Jeffrey L.
    JOURNAL OF ARRHYTHMIA, 2022, 38 (06) : 997 - 1008
  • [25] Failure Mode and Effects Analysis (FMEA) method applied to anticoagulation of patients with non-valvular atrial fibrillation
    Atienza-Martin, F.
    Barrios, V
    Egocheaga, M., I
    Hidalgo, R.
    Marin-Montanes, N.
    Ramis, C.
    MEDICINA DE FAMILIA-SEMERGEN, 2019, 45 (03): : 169 - 179
  • [26] Non-persistence to Oral Anticoagulation Therapy in Elderly Patients with Non-valvular Atrial Fibrillation
    Cao, Yue
    Feng, Yue-Yue
    Du, Wei
    Li, Jing
    Fei, Ya-Lan
    Yang, Hao
    Wang, Meng
    Li, Shi-Jie
    Li, Xian-Jin
    Han, Bing
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 3185 - 3194
  • [27] Anticoagulation in patients with non-valvular atrial fibrillation (nvAF) and chronic kidney disease (CKD)
    Zeymer, Uwe
    Bonnemeier, Hendrik
    Wanner, Christoph
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (23) : 1642 - 1649
  • [28] Anticoagulation for stroke prevention in elderly patients with non-valvular atrial fibrillation: what are the obstacles?
    Wong, C. W.
    HONG KONG MEDICAL JOURNAL, 2016, 22 (06) : 608 - 615
  • [29] Cost analysis: apixaban versus other anticoagulation in patients with non-valvular atrial fibrillation
    Kunde, Katharina
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2022, 27 (06): : 282 - 283
  • [30] RISK OF THROMBOEMBOLISM IN NON-VALVULAR ATRIAL FIBRILLATION AND ADEQUACY OF ANTICOAGULATION IN HIGH RISK PATIENTS
    Farooq, Fawad
    Hashim, Muhammad
    Khalid, Muhammad Rahman
    Karim, Musa
    PAKISTAN HEART JOURNAL, 2018, 51 (04): : 314 - 318